Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Gregory Botta

Photo of Gregory Botta
Title(s)Associate Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
Emailgbotta@ucsd.edu
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Carnegie Mellon University, PittsburghBS05/2004Information Systems & Biomedical Engineering
    University of Pittsburgh, Pittsburgh04/2006Biomedical Engineering
    Drexel University, PhiladelphiaPhD01/2012Molecular & Cellular Biology and Genetics
    University of Pennsylvania, PhiladelphiaPost-Doctoral05/2014Cancer Biology and Stem Cells
    Drexel University College of Medicine, PhiladelphiaMD05/2014Medicine

    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    iRGD Reprogramming of Metabolically Suppressed Pancreatic Cancer
    NCI LRP KYGF9753Nov 1, 2018 - Nov 1, 2020
    Role: Principal Investigator
    Institutional Career Development Core
    NIH KL2TR002552May 1, 2018 - Apr 30, 2023
    Role: Co-Investigator
    Scripps Translational Science Institute
    NIH KL2TR001112Sep 26, 2013 - Apr 30, 2018
    Role: Co-Investigator
    Induced Reactive Oxygen Species in a 3-D Human Pancreatitis Model in Vitro
    NIH F30DK088402Jul 1, 2010 - Jun 30, 2014
    Role: Principal Investigator
    Scripps Translational Science Institute (KL2)
    NIH KL2TR000110May 19, 2008 - Oct 31, 2013
    Role: Co-Investigator
    Scripps Translational Science Institute (KL2)
    NIH KL2RR025773May 19, 2008 - Apr 30, 2013
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group. JCO Precis Oncol. 2025 Mar; 9:e2400489. Rajdev L, King GG, Lieu CH, Cohen SA, Pant S, Uboha NV, Deming D, Malla M, Kasi A, Klute K, Spencer KR, Dasari A, Morris VK, Botta G, Lowy AM, O'Hara MH, Eads J, King D, Shah MA, Hong TS, Parikh A, Klempner SJ, Jabbour SK, Chawla A, Molena D, George TJ, Gibson MK, Allegra C, Goodman K, Eng C, Philip PA. PMID: 40048671; PMCID: PMC11893001.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations. J Clin Oncol. 2025 Feb 20; 43(6):705-715. Weitz J, Nishizaki D, Liau J, Patel J, Ng I, Sun S, Ramms D, Zou J, Wishart B, Rull J, Baumgartner J, Kelly K, White R, Veerapong J, Hosseini M, Patel H, Botta G, Gutkind JS, Tiriac H, Kato S, Lowy AM. PMID: 39413348; PMCID: PMC11829827.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    3. Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. Oncologist. 2024 Oct 03; 29(10):859-869. Botta GP, Abdelrahim M, Drengler RL, Aushev VN, Esmail A, Laliotis G, Brewer CM, George GV, Abbate SM, Chandana SR, Tejani MA, Malla M, Bansal D, Rivero-Hinojosa S, Spickard E, McCormick N, Cecchini M, Lacy J, Fei N, Kasi PM, Kasi A, Dayyani F, Hanna DL, Sharma S, Malhotra M, Aleshin A, Liu MC, Jurdi A. PMID: 39022993; PMCID: PMC11449101.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    4. Viewing the immune checkpoint VISTA: landscape and outcomes across cancers. ESMO Open. 2024 Apr; 9(4):102942. Nishizaki D, Kurzrock R, Miyashita H, Adashek JJ, Lee S, Nikanjam M, Eskander RN, Patel H, Botta GP, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S. PMID: 38503143; PMCID: PMC10966162.
      View in: PubMed   Mentions: 11  Translation:Humans
    5. Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells. J Immunother Cancer. 2024 02 05; 12(2). Botta GP, Chao J, Ma H, Hahn M, Sierra G, Jia J, Hendrix AY, Nolte Fong JV, Ween A, Vu P, Miller A, Choi M, Heyman B, Daniels GA, Kaufman D, Jamieson C, Li Z, Cohen E. PMID: 38316518; PMCID: PMC10860094.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    6. Challenges and prospects of CSF1R targeting for advanced malignancies. Am J Cancer Res. 2023; 13(7):3257-3265. Moeller A, Kurzrock R, Botta GP, Adashek JJ, Patel H, Lee S, Pabla S, Nesline MK, Conroy J, Sicklick JK, Kato S. PMID: 37560003; PMCID: PMC10408490.
      View in: PubMed   Mentions: 9  
    7. Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases. J Gastrointest Cancer. 2024 Mar; 55(1):41-46. Baumgartner JM, Botta GP. PMID: 37436640; PMCID: PMC11096195.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    8. Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma. Oncologist. 2023 03 17; 28(3):220-229. Azzi G, Tavallai M, Aushev VN, Koyen Malashevich A, Botta GP, Tejani MA, Hanna D, Krinshpun S, Malhotra M, Jurdi A, Aleshin A, Kasi PM. PMID: 36562592; PMCID: PMC10020810.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    9. Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis. NPJ Genom Med. 2023 Jan 20; 8(1):1. Shaya J, Kato S, Adashek JJ, Patel H, Fanta PT, Botta GP, Sicklick JK, Kurzrock R. PMID: 36670111; PMCID: PMC9860045.
      View in: PubMed   Mentions: 17  
    10. Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients. Cancer Med. 2023 04; 12(7):7713-7723. Botta GP, Huynh TR, Spierling-Bagsic SR, Agelidis A, Schaffer R, Lin R, Sigal D. PMID: 36478411; PMCID: PMC10134275.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers. JCO Precis Oncol. 2022 12; 6:e2200420. Huffman BM, Aushev VN, Budde GL, Chao J, Dayyani F, Hanna D, Botta GP, Catenacci DVT, Maron SB, Krinshpun S, Sharma S, George GV, Malhotra M, Jurdi A, Moshkevich S, Aleshin A, Kasi PM, Klempner SJ. PMID: 36480779; PMCID: PMC10530958.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    12. Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy. NPJ Precis Oncol. 2022 Sep 22; 6(1):67. Louie BH, Kato S, Kim KH, Lim HJ, Okamura R, Eskander RN, Botta G, Patel H, Lee S, Lippman SM, Sicklick JK, Kurzrock R. PMID: 36138116; PMCID: PMC9500013.
      View in: PubMed   Mentions: 5  
    13. SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy. Mol Cancer Ther. 2021 12; 20(12):2341-2351. Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R. PMID: 34642211; PMCID: PMC8643328.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    14. SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer. JCI Insight. 2021 09 22; 6(18). Botta GP, Kato S, Patel H, Fanta P, Lee S, Okamura R, Kurzrock R. PMID: 34375311; PMCID: PMC8492298.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    15. Tri-modal management of primary small cell carcinoma of the pancreas (SCCP): a rare neuroendocrine carcinoma (NEC). BMC Gastroenterol. 2021 Sep 03; 21(1):340. Elzein S, Bao F, Lin R, Schnickel G, Lowy AM, Botta GP. PMID: 34479480; PMCID: PMC8414857.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Tumor-penetrating therapy for β5 integrin-rich pancreas cancer. Nat Commun. 2021 03 09; 12(1):1541. Hurtado de Mendoza T, Mose ES, Botta GP, Braun GB, Kotamraju VR, French RP, Suzuki K, Miyamura N, Teesalu T, Ruoslahti E, Lowy AM, Sugahara KN. PMID: 33750829; PMCID: PMC7943581.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    17. Hemorrhagic Cystitis: Treatment With Hyperbaric Oxygen Therapy in Patients With Acute Lymphoblastic Leukemia. Clin J Oncol Nurs. 2018 12 01; 22(6):E146-E151. Botta LM, Botta GP. PMID: 30451996.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome. Mol Clin Oncol. 2018 04; 8(4):609-612. Bhangoo MS, Cheng B, Botta GP, Thorson P, Kosty MP. PMID: 29541472; PMCID: PMC5838296.
      View in: PubMed   Mentions: 12  
    19. Advances on immunotherapy in genitourinary and renal cell carcinoma. Transl Cancer Res. 2017 Feb; 6(1):17-29. Botta GP, Granowicz E, Costantini C. PMID: 28966917; PMCID: PMC5617347.
      View in: PubMed   Mentions: 6  
    20. Spontaneous Iliopsoas Muscle Hemorrhage Secondary to Ibrutinib (Imbruvica; Pharmacyclics): Brief Report. J Investig Med High Impact Case Rep. 2016 Apr-Jun; 4(2):2324709616648457. Sarcon A, Botta GP, Patel N, Saven A. PMID: 27231694; PMCID: PMC4871198.
      View in: PubMed   Mentions:    Fields:    
    21. Isolation, culture and genetic manipulation of mouse pancreatic ductal cells. Nat Protoc. 2013; 8(7):1354-65. Reichert M, Takano S, Heeg S, Bakir B, Botta GP, Rustgi AK. PMID: 23787893; PMCID: PMC4121532.
      View in: PubMed   Mentions: 63     Fields:    Translation:AnimalsCells
    22. ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells. Neoplasia. 2013 Apr; 15(4):359-72. Botta GP, Reichert M, Reginato MJ, Heeg S, Rustgi AK, Lelkes PI. PMID: 23555182; PMCID: PMC3612909.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    23. Electrospun hydroxyapatite-containing chitosan nanofibers crosslinked with genipin for bone tissue engineering. Biomaterials. 2012 Dec; 33(36):9167-78. Frohbergh ME, Katsman A, Botta GP, Lazarovici P, Schauer CL, Wegst UG, Lelkes PI. PMID: 23022346; PMCID: PMC3488354.
      View in: PubMed   Mentions: 94     Fields:    Translation:AnimalsCells
    24. Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1. Mol Cancer Res. 2012 Feb; 10(2):183-96. Botta GP, Reginato MJ, Reichert M, Rustgi AK, Lelkes PI. PMID: 22160930; PMCID: PMC3288768.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    25. Sex of muscle stem cells does not influence potency for cardiac cell therapy. Cell Transplant. 2009; 18(10):1137-46. Drowley L, Okada M, Payne TR, Botta GP, Oshima H, Keller BB, Tobita K, Huard J. PMID: 19523348.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    26. Real-time assessment of three-dimensional cell aggregation in rotating wall vessel bioreactors in vitro. Nat Protoc. 2006; 1(4):2116-27. Botta GP, Manley P, Miller S, Lelkes PI. PMID: 17487203.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    Gregory's Networks
    Concepts (153)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (30)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-18-gb39b692b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California